Goldman Sachs’s Astera Labs ALAB Stock Holding History
Bought
Maintained
Sold
Other funds holding ALAB
VPM
VCM
AM
FAM
Goldman Sachs's ALAB Position: Q1 2026 in Review
Goldman Sachs increased its Astera Labs (ALAB) stake by 5.1% in Q1 2026, buying an estimated $9.57M and bringing the position to 1,380,114 shares worth $151M. The position accounts for 0.02% of the portfolio, ranked #817.
Goldman Sachs first reported a position in ALAB in Q2 2024 and has held it in 8 quarters since. The position peaked at $218M in Q4 2025. 703 funds tracked by Wall St. Rank hold ALAB as of Q1 2026.
- Goldman Sachs held 1,380,114 shares of Astera Labs worth $151M as of Q1 2026.
- Goldman Sachs bought 67,187 Astera Labs shares in Q1 2026, an estimated $9.57M.
- Astera Labs made up 0.02% of Goldman Sachs's portfolio in Q1 2026, its #817 holding.
- Goldman Sachs first reported a position in Astera Labs in Q2 2024 and has held it in 8 quarters since.
- Goldman Sachs's Astera Labs position peaked at $218M in Q4 2025.
- 703 funds tracked by Wall St. Rank held Astera Labs as of Q1 2026.
Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.